Skip to main content

Closed

VCEL: Vericel Corporation Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Mixed

Revenue growth+20.1% / yr

Operating margin6.0%

ROIC3.8%

Financially safe

Strong

Debt / equity0.25×

Interest coverage28.5×

Current ratio5.04×

Valuation

Unrated

P/E ratio95.8×

Vericel Corporation

VCELNASDAQ Capital Market·USD·Closed

Vericel Corporation

VCELNASDAQ·USD·Closed

$45.96

−3.47%

$45.96

−$1.65 (3.47%)

52W Range

84thpctl

Volume

0.80×avg

Mkt Cap

2.35BUSD

P/E

95.8TTM

Div Yield

–ann

52W Range

84thpctl

Volume

0.80×avg

Market Cap

2.35BUSD

P/E Ratio

95.8TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings